3. Góralczyk-Bińkowska A, Szmajda-Krygier D, Kozłowska E. The Microbio-
ta-gut-brain axis in psychiatric disorders. Int J Mol Sci 2022;23(19):11245.
DOI:...
4. Huang Y, Liao J, Liu X, Zhong Y, Cai X, Long L. Review: The role of intestinal
dysbiosis in Parkinson’s disease. Front Cell Infect Microbiol...
5. Fang X, Li F-J, Hong D-J. Potential role of Akkermansia muciniphila in Par-
kinson’s disease and other neurological/autoimmune diseases....
6. Maini Rekdal V, Bess EN, Bisanz JE, Turnbaugh PJ, Balskus EP. Discovery and
inhibition of an interspecies gut bacterial pathway for Levodopa...
7. van Kessel SP, de Jong HR, Winkel SL, van Leeuwen SS, Nelemans SA, Permenti-
er H, et al. Gut bacterial deamination of residual levodopa...
8. Tian R, Hong J, Zhao J, Zhou D, Liu Y, Jiao Z, et al. Overall structural
alteration of gut Microbiota and relationships with risk factors...
9. Nishiwaki H, Ito M, Ishida T, Hamaguchi T, Maeda T, Kashihara K, et
al. Meta-analysis of gut dysbiosis in Parkinson’s disease. Mov Disord
2020;35(9):1626-35....
10. Hamamah S, Aghazarian A, Nazaryan A, Hajnal A, Covasa M. Role of Micro-
biota-gut-brain axis in regulating dopaminergic signaling. Biomedicines
2022;10(2):436....